Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

November 30, 2007

Conditions
Pneumonia
Interventions
DRUG

Levofloxacin

DRUG

Piperacillin/Tazobactam

Trial Locations (17)

Unknown

Sanofi-Aventis, Vienna

Sanofi-Aventis, Brussels

Sanofi-Aventis, Prague

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Athens

Sanofi-Aventis, Guatemala City

Sanofi-Aventis, Milan

Sanofi-Aventis, Beirut

Sanofi-Aventis, México

Sanofi-Aventis, Gouda

Sanofi-Aventis, Bucharest

Sanofi-Aventis, Moscow

Sanofi-Aventis, Johannesburg

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Istanbul

Sanofi-Aventis, Caracas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00253955 - Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia | Biotech Hunter | Biotech Hunter